LAVR-289, a new acyclo-nucleoside phosphonate having broad-spectrum activity against herpesviruses.
Sandrine Kappler‐Gratias, Charlotte Quentin-Froignant, Elie Marcheteau, José Fernandez, David Boutolleau, Virginie Garcia, Vincent Roy, Luigi André Agrofoglio, Franck Gallardo
This study evaluates LAVR-289, a new antiviral compound, showing broad-spectrum activity against herpesviruses and resistance to existing treatments.
bioRxiv · Feb 20, 2025 · PreprintMicrobiology